Allurion Technologies Inc (ALUR)
1.86
-0.06
(-3.12%)
USD |
NYSE |
May 16, 16:00
1.88
+0.02
(+1.08%)
Pre-Market: 20:00
Allurion Technologies Cash from Investing (Quarterly): -0.398M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.398M |
| September 30, 2023 | -0.80M |
| June 30, 2023 | -0.131M |
| March 31, 2023 | -0.277M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.459M |
| September 30, 2022 | 0.157M |
| June 30, 2022 | -0.93M |
| March 31, 2022 | -0.318M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.93M
Minimum
Jun 2022
0.157M
Maximum
Sep 2022
-0.3945M
Average
-0.358M
Median
Cash from Investing (Quarterly) Benchmarks
| Outset Medical Inc | -59.03M |
| Paragon 28 Inc | -5.778M |
| Perspective Therapeutics Inc | -0.089M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 3.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.87M |
| Cash from Financing (Quarterly) | -20.41M |
| Free Cash Flow | -65.59M |
| Free Cash Flow Per Share (Quarterly) | -0.4463 |
| Free Cash Flow to Equity (Quarterly) | -2.235M |
| Free Cash Flow to Firm (Quarterly) | -18.00M |
| Free Cash Flow Yield | -77.93% |